Examination of specimens for mycobacteria in clinical laboratories in 21 countries: a 10- year review of the UK National Quality Assessment Scheme for.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

Molecular evolution of Mycobacterium tuberculosis

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Migrant health—a cause for concern?

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria Maurizia Debiaggi, Francesca Zara, Roberto Brerra, Giorgio.

J.-P. Van geertruyden Clinical Microbiology and Infection

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review M. Drancourt

Clinical Microbiology and Infection

Results from a mathematical model for human monocytic ehrlichiosis

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

Non-tuberculous mycobacterial keratitis

E.C. Böttger Clinical Microbiology and Infection

Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination M.-R. Lee,

Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience.

Laboratory diagnosis and biosafety issues of biological warfare agents

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

S. Borrell, S. Gagneux Clinical Microbiology and Infection

Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients Giampietro Nardi,

M. Or, M. Samish, T. Waner, S. Harrus

Rapidly growing mycobacteria in Singapore, 2006–2011

Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years T.G. Harrison, N. Doshi, N.K. Fry, C.A.

Levofloxacin in the treatment of ventilator-associated pneumonia

W. Saisongkorh, L. Barrassi, B. Davoust, C. -A. de Broucker, D

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin Ornella Soro, Adelaide.

Detection of, and frequent co-infection with, human bocavirus in faecal specimens from children in Wuhan, China Y. Huang, P. Mao, H. Wang Clinical Microbiology.

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

Update on antifungal resistance in Aspergillus and Candida

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

P.M. Hawkey Clinical Microbiology and Infection

A.P. Underwood, J. Green Clinical Microbiology and Infection

Andrew M. Middleton, Maureen V. Chadwick, Harold Gaya

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Listeriosis: a resurgent foodborne infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Survival of rhinoviruses on human fingers

F.J. Pastor, J. Guarro Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria N. Zamora, J. Esteban, T.J. Kinnari, A. Celdrán,

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

The state of measles and rubella in the WHO European Region, 2013

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

J. Esteban, A. Molleja, F. Cabria, M. Soledad Jimenez

Comparative study of pediculicidal effect of medical plants

Localized Mycobacterium avium complex infection in a patient on HAART

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Examination of specimens for mycobacteria in clinical laboratories in 21 countries: a 10- year review of the UK National Quality Assessment Scheme for Mycobacteria Culture C. Walton, P.M. Hawkey, V.L.A. James Clinical Microbiology and Infection Volume 11, Issue 12, Pages 1016-1021 (December 2005) DOI: 10.1111/j.1469-0691.2005.01261.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Mean percentage of laboratories with fully correct results in successive EQA specimens containing Mycobacterium tuberculosis. Total percentage fully correct is the mean performance measured over all specimens distributed within the same year. AAFB, atypical acid-fast bacteria. Clinical Microbiology and Infection 2005 11, 1016-1021DOI: (10.1111/j.1469-0691.2005.01261.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Percentage of laboratories with completely correct results in four successive specimens containing mycobacteria other than Mycobacterium tuberculosis (MOTT) and one containing Mycobacterium bovis. When the number of specimens containing an MOTT strain was more than one, performance is expressed as the mean: for M. fortuitum, n = 1; for M. kansasii, n = 3; for M. chelonae, n = 1; for M. avium-intracellulare, n = 2; and for M. bovis, n = 1. AAFB, atypical acid-fast bacteria. Clinical Microbiology and Infection 2005 11, 1016-1021DOI: (10.1111/j.1469-0691.2005.01261.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions